Is RCG Corporation Limited the best retail stock on the ASX?

RCG Corporation Limited (ASX:RCG) delivered a robust full-year result with brighter pastures ahead.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This morning, RCG Corporation Limited (ASX: RCG) delivered yet another strong full year profit result for shareholders.

In the year to 28 June 2015, the owner of The Athlete's Foot and exclusive distributor of many popular international footwear brands to Australia and New Zealand reported a healthy jump in revenue and underlying profit.

On a statutory basis, revenue jumped 67.4% to $135 million, but profit fell 11.7% to $10.3 million. However, excluding the $3.6 million in transaction costs arising from the group's acquisition of the Accent Group in May, profit growth would have jumped well into double digits – underlying net profit was up 16%.

The performance of The Athlete's Foot (TAF) was perhaps the only blemish on an otherwise promising annual report. TAF reported like-for-like sales growth of 1.2% for the year. However, CEO Hilton Brett said the group is undertaking a strategic review of its market position and consumer offering.

Nevertheless, he said the business' focus on service differentiates it from competitors. He added: "As a consequence, it has been able to maintain its position as a premium full‐price retailer, despite ongoing aggressive price activity in its sector."

RCG Brands, which houses Podium Sports, Merrell retail stores and much more, reported wholesale sales growth of 24% and retail sales growth of 55%.

"The outstanding results are a testament to the efforts of the team and the quality of the brands that they distribute," Mr Brett said. "We are particularly pleased with the performance of Saucony, CAT and Sperry with all three brands experiencing growth both through existing and new channels."

Finally, Accent Group performed well for the brief amount of time which RCG ran the business. The importer, distributor and retailer of names like Skechers, Vans, Dr Martens, Timberland and much more delivered like-for-like sales growth, for the five-week period of 31%.

Mr Brett said: "The ongoing performance of the Accent business is unprecedented in the current retail climate, with over 30% like‐for‐like growth over the last 12 months and double digit like‐for‐ like growth in each of the two years before that."

While RCG's final dividend is only in line with last year's payment of 2.5 cents per share (and no dividend reinvestment plan will apply), Mr Brett said the company chose not to increase the payout because it will continue to invest in the newly acquired Accent Group.

He said the board believes further investment in the retail division, "will deliver enormous long‐term value accretion."

Furthermore, "we intend to at least maintain the historical dividends per share with a view to increasing this over time, when operating cashflow allows," he said.

The best retail stock on the ASX

The outlook provided by the company was positive, forecasting underlying earnings per share (EPS) growth of 25% to 30%. However, the group did acknowledge the retail environment and the recent integration of Accent make forecasting challenging.

Following the profit result and subsequent fall in share price, investing in RCG is appealing at today's prices. While some including myself may argue retailers are fickle and prone to profit downgrades, if I were forced to pick just one ASX retailer to buy, RCG Corp would be my choice.

Motley Fool contributor Owen Raskiewicz has no position in any stocks mentioned. Owen welcomes your feedback on Google+ (see below), LinkedIn or you can follow him on Twitter @ASXinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »